We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Definition of Emerging Microplastic Syndrome Based on Clinical and Epidemiological Evidence: A Narrative Review
AI summary Read the abstract
This paper proposes a new medical concept called "Microplastic Syndrome" based on clinical evidence and rising disease rates in Italy coinciding with increased plastic production. Researchers developed a 30-question diagnostic tool that looks at lab markers, clinical signs, and ultrasound findings to identify people potentially affected by microplastic accumulation. While this framework needs further validation through long-term studies, it represents an early attempt to formally define and diagnose health problems linked to microplastic exposure.
Microplastics and nanoplastics (MNPs) are pervasive contaminants infiltrating water, food, and human tissues. The sharp rise in plastic production—with over half manufactured between 2003 and 2022—has heightened concerns about their health impacts. Methods included: (1) a literature review of clinical studies on MNPs focusing on human health and (2) analysis of Standardized Mortality Rates (SMRs) for 44 groups of diseases in Italy (2003–2022, Italian National Institute of Statistics, ISTAT data). The outcomes suggest that MNPs have been connected to pathological alterations in a number of organ systems, such as the gastrointestinal tract (intestine, liver, and pancreas), breathing system, eyes, brain, and vascular structures. SMRs increased significantly in only eight of the 46 illness categories examined between 2003 and 2022. The analysis of clinical and epidemiological data allows us to identify a possible clinical assessment consisting of a 30-variable diagnostic questionnaire (Chicago Cluster Evaluation System, CCES), encompassing laboratory markers, clinical signs, and ultrasound findings. A binomial distribution model suggests that more than 8 positive responses may indicate a presumptive diagnosis of Microplastic Syndrome (MP-Sy). This framework reflects observed clinical/epidemiological patterns and provides a foundation for hypothesis-driven research. Prospective longitudinal studies are warranted to validate the proposed definition and its diagnostic utility. The aim of the present study is to propose a preliminary clinical framework for a potential MP-Sy integrating toxicological evidence with epidemiological data, define diagnostic criteria and assess their consistency with observed disease trends.
More Papers Like This
Emerging Analytical Methodologies for Micro- and Nano-Plastics Detection in Human Samples: Analytical Challenges and Health Risk Perspectives
AI summary Read the abstract
Scientists have found tiny plastic particles (microplastics and even smaller nanoplastics) throughout human organs and body fluids, but this review of existing research shows we still lack reliable, standardized tools to accurately measure them—different labs get different results depending on how they prepare and test samples. While lab studies suggest very small plastic particles can cause cell stress and inflammation, there isn't yet solid evidence directly linking plastic exposure to specific diseases in people—so the biggest takeaway is that we urgently need better testing methods before we can truly understand the health risks these particles pose.
Mikroplastik sebagai Kontaminan Anyar dan Efek Toksiknya terhadap Kesehatan
AI summary Read the abstract
This Indonesian review examines microplastic definition, formation, accumulation, toxicokinetics, and potential pathological effects in humans, with emphasis on biomolecular mechanisms. The authors call for Indonesian healthcare personnel to increase their knowledge of microplastic exposure routes and health implications given Indonesia's status as a major plastic-producing maritime nation.
Mapping Clinical Disease Patterns Potentially Associated with Microplastic Exposure: A Narrative Review across Twenty-One Disease Categories
AI summary Read the abstract
This narrative review mapped clinical disease patterns potentially associated with microplastic exposure across 21 disease categories encompassing 375 illnesses. Researchers found emerging patterns linking microplastic and nanoplastic exposure to inflammatory, metabolic, and neurological outcomes, though the study emphasizes that many of these associations require further investigation to establish clear causal relationships.
[Clinical impact of microplastic exposure in humans].
AI summary Read the abstract
This German-language clinical review summarized current knowledge on microplastic exposure pathways, health risks, and the World Health Organization's assessment of this topic. The authors noted significant gaps in measuring microplastics in the human body and called for improved methods to assess clinical impacts, particularly links to infectious disease.
[Clinical impact of microplastic exposure in humans].
AI summary Read the abstract
This review summarized clinical evidence on the health impacts of microplastic exposure in humans, covering routes of entry (air, food, contact) and the range of organ systems affected. It concluded that while data are still emerging, current evidence supports concern about microplastic accumulation and its potential to cause inflammation, oxidative stress, and systemic health effects.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.